CSIMarket
 


Biotricity Inc   (BTCY)
Other Ticker:  
 
 

BTCY's Income from Cont. Operations Growth by Quarter and Year

Biotricity Inc 's Income from Cont. Operations results by quarter and year




BTCY Income from Cont. Operations (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter March - -5.61 -5.47 -4.60
III Quarter December - -7.11 -3.90 -2.37
II Quarter September -4.69 -10.75 -2.96 -2.01
I Quarter June -4.78 -5.66 -3.16 -2.09
FY   -9.47 -29.13 -15.49 -11.07



BTCY Income from Cont. Operations second quarter 2023 Y/Y Growth Comment
Biotricity Inc in the second quarter 2023 recorded loss from continued operations of $ -4.69 millions.

According to the results reported in the second quarter 2023, Biotricity Inc achieved the best Income from Cont. Operations growth in Medical Equipment & Supplies industry. While Biotricity Inc ' s Income from Cont. Operations no change of % ranks overall at the positon no. in the second quarter 2023.




BTCY Income from Cont. Operations ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter March - - - -
III Quarter December - - - -
II Quarter September - - - -
I Quarter June - - - -
FY   - - - -

Financial Statements
Biotricity Inc 's second quarter 2023 Income from Cont. Operations $ -4.69 millions BTCY's Income Statement
Biotricity Inc 's second quarter 2022 Income from Cont. Operations $ -10.75 millions Quarterly BTCY's Income Statement
New: More BTCY's historic Income from Cont. Operations Growth >>


BTCY Income from Cont. Operations (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter March - - - -
III Quarter December - - - -
II Quarter September - - - -
I Quarter June - - - -
FY (Year on Year)   - - - -




Income from Cont. Operations second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Income from Cont. Operations second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Income from Cont. Operations by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Biotricity Inc 's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BTCY's II. Quarter Q/Q Income from Cont. Operations Comment
Despite the fact, that Biotricity Inc in the II. Quarter 2023 admitted loss from continued operations of $ -4.69 millions, management point out, that those numbers show recovery compare to the -4.78 millions in the first quarter.

Within Medical Equipment & Supplies industry Biotricity Inc achieved highest sequential Income from Cont. Operations growth. While Biotricity Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BTCY's II. Quarter Q/Q Income from Cont. Operations Comment
Although Biotricity Inc in the II. Quarter 2023 showed loss from continued operations of $ -4.69 millions, management point out, that current results point to slight up side relative to the -4.78 millions in the first quarter.

Within Medical Equipment & Supplies industry Biotricity Inc achieved highest sequential Income from Cont. Operations growth. While Biotricity Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Biotricity Inc 's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Income from Cont. Operations 12 Months Ending $ -22.19 $ -28.25 $ -29.13 $ -28.99 $ -25.78
Y / Y Income from Cont. Operations Growth (TTM) - - - - -
Year on Year Income from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential Income from Cont. Operations Change (TTM) - - - - -
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative Income from Cont. Operations growth Comment


Biotricity Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Income from Cont. Operations growth Comment


Biotricity Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Income from Cont. Operations Growth
Medical Equipment & Supplies Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
BTCY's Income from Cont. Operations Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for BTCY's Competitors
Income from Cont. Operations Growth for Biotricity Inc 's Suppliers
Income from Cont. Operations Growth for BTCY's Customers

You may also want to know
BTCY's Annual Growth Rates BTCY's Profitability Ratios BTCY's Asset Turnover Ratio BTCY's Dividend Growth
BTCY's Roe BTCY's Valuation Ratios BTCY's Financial Strength Ratios BTCY's Dividend Payout Ratio
BTCY's Roa BTCY's Inventory Turnover Ratio BTCY's Growth Rates BTCY's Dividend Comparisons



Companies with similar Income from Cont. Operations no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Sep 30 2022
Addus Homecare Corporation-0.29%$ -0.294 millions
Royalty Pharma Plc-0.62%$ -0.623 millions
Zoetis Inc -4.35%$ -4.348 millions
Henry Schein Inc-4.41%$ -4.410 millions
Charles River Laboratories International inc -7.18%$ -7.177 millions
Sotera Health Company-8.58%$ -8.577 millions
U S Physical Therapy Inc-9.22%$ -9.219 millions
Pediatrix Medical Group Inc -9.52%$ -9.523 millions
Ironwood Pharmaceuticals inc -9.90%$ -9.899 millions
Semler Scientific Inc -11.45%$ -11.446 millions
National Research Corporation-14.07%$ -14.073 millions
Meridian Bioscience Inc -14.30%$ -14.301 millions
Elite Pharmaceuticals Inc -15.68%$ -15.684 millions
Lemaitre Vascular Inc -16.11%$ -16.113 millions
Intuitive Surgical Inc -16.14%$ -16.142 millions
Retractable Technologies inc -17.43%$ -17.428 millions
Molecular Templates inc -18.92%$ -18.919 millions
Regeneron Pharmaceuticals Inc -19.39%$ -19.391 millions
Universal Health Services Inc -19.40%$ -19.402 millions
Zynex inc -20.21%$ -20.206 millions
Progyny Inc -21.34%$ -21.344 millions
Tenax Therapeutics Inc -23.22%$ -23.222 millions
Maravai Lifesciences Holdings Inc -24.97%$ -24.966 millions
Merck and Co Inc -28.83%$ -28.834 millions
Organon and Co -29.72%$ -29.721 millions
Gilead Sciences Inc -30.94%$ -30.936 millions
West Pharmaceutical Services Inc -31.32%$ -31.321 millions
Abbott Laboratories-31.67%$ -31.667 millions
Surgery Partners Inc -31.71%$ -31.707 millions
Biomx Inc -32.41%$ -32.410 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com